Found 1259 results for "cancer"
The devastating reality of glioblastoma—where patients face a 15-month median survival and less than 7% live beyond five years—may be shifting as microfluidic…
Even brief periods of poor dietary choices may compromise immune function for months through a previously unknown mechanism of metabolic scarring in cancer-fig…
Treatment-resistant ovarian cancer represents one of oncology's most challenging frontiers, with most patients developing resistance to standard platinum-based…
Cancer patients undergoing chemotherapy often struggle with cognitive fog that can persist for months or years, limiting their ability to work, drive, and main…
The promise of precision immunotherapy for lung cancer patients hinges on solving a fundamental challenge: determining which patients will benefit from expensi…
The discovery that a single DNA repair enzyme can either help or hinder viral infections depending on the pathogen reveals new therapeutic vulnerabilities in r…
A particularly aggressive form of ovarian cancer that resists conventional chemotherapy may finally have a vulnerable target. Low-grade serous ovarian cancer a…
Pancreatic cancer's notorious resistance to targeted therapy may have found its match through an unexpected metabolic vulnerability. When pancreatic tumors dev…
A breakthrough in liver cancer detection could transform screening for HIV patients in resource-limited settings, where hepatocellular carcinoma remains a lead…
Drug delivery precision could advance significantly as engineered peptide carriers demonstrate superior targeting capabilities compared to conventional pharmac…
The personalized medicine era demands better prediction of which cancer treatments will succeed for individual patients. This comprehensive analysis of nearly…
Cancer's ability to colonize distant organs may depend less on the tumor cells themselves and more on how they manipulate the immune system's cellular landscap…
Chromosomal stability represents a crucial battleground in cancer prevention, with new evidence revealing how a previously understudied cellular quality contro…
Drug resistance remains one of the most formidable barriers in cancer treatment, turning initially effective therapies into futile interventions. This discover…
The majority of colorectal cancers resist immunotherapy because they lack the molecular signatures that make tumors visible to immune surveillance. This repres…
Preventing cancer before it fully develops represents one of medicine's most compelling opportunities, particularly for blood cancers where early intervention…
Pancreatic ductal adenocarcinoma represents one of medicine's most formidable challenges, with five-year survival rates remaining stubbornly below 10 percent.…
Dietary choices may hold significant power in reducing women's vulnerability to one of gynecology's most challenging malignancies. The distinction between whol…
Geographic isolation and cultural barriers are creating dangerous treatment gaps for head and neck cancer patients in regional Australia, with Indigenous commu…
Cancer vaccination strategies traditionally focus on immune system priming while leaving tumor metabolism untouched—a limitation that may explain why many prom…